Search results
If Not President Biden, Then Who?
New York Times· 5 days agoDemocrats and donors are pondering who could be the best alternative to take on Donald Trump after faltering attempts to calm nerves following last...
Revealed: the 103 professional lobbyists standing in the 2024 general election
The New Statesman· 6 days agoHanbury is a registered lobbying firm whose clients, during the time that Ward has been a director,...
InnovationRx: A Fourth Dairy Worker Has Contracted Avian Flu
Forbes· 6 days agoInnovationRx is your weekly digest of healthcare news. Today, the Colorado Department of Public...
Hormone Replacement Therapy Market Poised for Steady Growth, Forecasted to Reach USD 23,729.6 Millio
PharmiWeb· 6 days agoThe hormone replacement therapy market is set to experience steady growth, projecting a compound annual growth rate (CAGR) of 3.5% over the forecast period. A< ...
Novo, Lilly Fall After Biden Calls for Cheaper Obesity Drugs
Bloomberg via Yahoo Finance UK· 6 days ago(Bloomberg) -- Novo Nordisk A/S and Eli Lilly & Co. shares fell Tuesday after US President Joe Biden...
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
CNN via Yahoo News UK· 6 days agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease.
Best Performing ETFs by Sector in the Past 30 Days
Zacks via Yahoo Finance UK· 6 days agoGoing forward, a steady annual growth rate (CAGR 2024-2029) of 4.87% is expected for the industry, resulting in a market volume of $266.40 billion by...
Approval of Newest Alzheimer’s Drug Will Accelerate New Era of Treatment
The Wall Street Journal· 6 days agoLilly's Kisunla was shown in a study to slow the decline of Alzheimer's patients.
New Drug Approved for Early Alzheimer’s
New York Times· 6 days agoThe drug, by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also...
Labour’s first policy should be to break up the NHS
The New Statesman· 6 days agoContemplating Labour’s 2024 manifesto, I wonder what Wes Streeting might have up his sleeve were he to become secretary of state for health. The most...